share_log
Breakings ·  Sep 11 05:23
T. Rowe Price Associates, Inc Reports Passive Stake of 19.99% in Tenax Therapeutics Inc as of August 31, 2024- SEC Filing
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment